Covered recipient · General Payments record
MOHAMEDAMR H AHMED HOSNY
Allopathic & Osteopathic Physicians Pain Medicine Interventional Pain Medicine
General Payments · PY2018–2024
$2,091.18
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $743.38 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $244.15 | 24 |
| Medtronic, Inc. | $145.93 | 1 |
| Pharmacosmos Therapeutics Inc. | $108.53 | 1 |
| Cook Medical LLC | $95.52 | 1 |
| Teva Pharmaceuticals USA, Inc. | $61.70 | 4 |
| SI-BONE, INC. | $32.50 | 1 |
| PFIZER INC. | $26.73 | 1 |
| Lilly USA, LLC | $14.69 | 1 |
| Collegium Pharmaceutical, Inc. | $13.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.11 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187392 | CMS |
| ABBVIE INC. | $7.66 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187394 | CMS |
| ABBVIE INC. | $12.73 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187396 | CMS |
| ABBVIE INC. | $6.00 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187398 | CMS |
| ABBVIE INC. | $11.16 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187400 | CMS |
| ABBVIE INC. | $8.01 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187402 | CMS |
| ABBVIE INC. | $2.43 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187404 | CMS |
| ABBVIE INC. | $9.05 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187406 | CMS |
| ABBVIE INC. | $15.68 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187408 | CMS |
| ABBVIE INC. | $5.98 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187410 | CMS |
| ABBVIE INC. | $17.37 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187412 | CMS |
| ABBVIE INC. | $8.15 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187414 | CMS |
| ABBVIE INC. | $8.03 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187416 | CMS |
| ABBVIE INC. | $16.05 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187418 | CMS |
| ABBVIE INC. | $4.35 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187420 | CMS |
| ABBVIE INC. | $17.47 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187422 | CMS |
| ABBVIE INC. | $9.68 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187424 | CMS |
| ABBVIE INC. | $7.96 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187426 | CMS |
| ABBVIE INC. | $11.84 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187428 | CMS |
| ABBVIE INC. | $11.62 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187430 | CMS |
| ABBVIE INC. | $17.65 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187432 | CMS |
| ABBVIE INC. | $13.19 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187434 | CMS |
| ABBVIE INC. | $4.69 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187436 | CMS |
| ABBVIE INC. | $2.29 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103187438 | CMS |
| Collegium Pharmaceutical, Inc. | $13.63 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135311478 | CMS |
| Cook Medical LLC | $95.52 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118327846 | CMS |
| Lilly USA, LLC | $14.69 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135142099 | CMS |
| Medtronic, Inc. | $145.93 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119266008 | CMS |
| PFIZER INC. | $26.73 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131940647 | CMS |
| Pharmacosmos Therapeutics Inc. | $108.53 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154819507 | CMS |
| SI-BONE, INC. | $32.50 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120051842 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.41 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151636503 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.14 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151636537 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.93 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151636549 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.22 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151636797 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.